Getlabs
A platform to book convenient at-home lab appointments.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
* | $20.0m | Series A | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 330 % | - |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Getlabs provides at-home diagnostic services, sending mobile phlebotomists to collect lab samples, vitals, and other advanced diagnostics from patients in the comfort of their own homes or offices. This service is designed to improve patient outcomes and provides a convenient solution for individuals who may have difficulty traveling to a lab. The company partners with healthcare organizations to extend their reach and offers a direct-to-consumer option for scheduling appointments. Getlabs' business model is centered on providing a more accessible and efficient way to conduct diagnostic testing, which is a critical component of modern healthcare. By bridging the gap between healthcare providers and patients, Getlabs aims to streamline the diagnostic process and make it more patient-centric.
Keywords: at-home diagnostics, mobile phlebotomy, lab testing, healthcare services, patient care, medical diagnostics, home healthcare, diagnostic testing, health-tech, medical services